Search Results - "Mackinnon, A. C."

Refine Results
  1. 1
  2. 2

    The therapeutic potential of galectin-3 inhibition in fibrotic disease by Slack, R.J., Mills, R., Mackinnon, A.C.

    “…Galectin-3 is a beta-galactoside-binding mammalian lectin and part of the 15 member galectin family that are evolutionarily highly conserved. It is the only…”
    Get full text
    Journal Article
  3. 3

    Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure by Henderson, Neil C, Pollock, Katharine J, Frew, John, Mackinnon, Alison C, Flavell, Richard A, Davis, Roger J, Sethi, Tariq, Simpson, Kenneth J

    Published in Gut (01-07-2007)
    “…Background: Acute hepatic failure secondary to paracetamol poisoning is associated with high mortality. C-jun (NH2) terminal kinase (JNK) is a member of the…”
    Get full text
    Journal Article
  4. 4

    Approximate Bayesian computation reveals the factors that influence genetic diversity and population structure of foxsnakes by ROW, J. R., BROOKS, R. J., MacKINNON, C. A., LAWSON, A., CROTHER, B. I., WHITE, M., LOUGHEED, S. C.

    Published in Journal of evolutionary biology (01-11-2011)
    “…Contemporary geographical range and patterns of genetic diversity within species reflect complex interactions between multiple factors acting across spatial…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Patients with the worst outcomes after paracetamol (acetaminophen)‐induced liver failure have an early monocytopenia by Moore, J. K., MacKinnon, A. C., Man, T. Y., Manning, J. R., Forbes, S. J., Simpson, K. J.

    Published in Alimentary pharmacology & therapeutics (01-02-2017)
    “…Summary Background Acute liver failure (ALF) is associated with significant morbidity and mortality. Studies have implicated the immune response, especially…”
    Get full text
    Journal Article
  7. 7

    Extracellular matrix regulation of drug resistance in small-cell lung cancer by Hodkinson, P. S., Mackinnon, A. C., Sethi, T.

    Published in International journal of radiation biology (01-01-2007)
    “…Purpose: Lung cancer is the leading cause of cancer deaths in the developed world. Small cell lung cancer (SCLC) has the worst prognosis due to the emergence…”
    Get full text
    Journal Article
  8. 8

    ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through beta 1 integrin-dependent activation of PI3-kinase by Hodkinson, P S, Elliott, T, Wong, W S, Rintoul, R C, Mackinnon, A C, Haslett, C, Sethi, T

    Published in Cell death and differentiation (01-10-2006)
    “…The emergence of resistance to chemotherapy remains a principle problem in the treatment of small-cell lung cancer (SCLC). We demonstrate that extracellular…”
    Get full text
    Journal Article
  9. 9

    Increased gastrin-releasing peptide (GRP) receptor expression in tumour cells confers sensitivity to [Arg , -Trp , Phe ]-substance P (6-11)-induced growth inhibition by WATERS, C. M, MACKINNON, A. C, CUMMINGS, J, TUFAIL-HANIF, U, JODRELL, D, HASLETT, C, SETHI, T

    Published in British journal of cancer (02-06-2003)
    “…[Arg(6),D-Trp(7,9),N(me)Phe(8)]-substance P (6-11) (SP-G) is a novel anticancer agent that has recently completed phase I clinical trials. SP-G inhibits…”
    Get full text
    Journal Article
  10. 10

    [Arg ,D-Trp ,N Phe ]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism by MACKINNON, A. C, ARMSTRONG, R. A, WATERS, C. M, CUMMINGS, J, SMYTH, J. F, HASLETT, C, SETHI, T

    Published in British Journal of Cancer (01-06-1999)
    “…[Arg6,D-Trp7,9,NmePhe8]-substance P (6-11) (antagonist G) is a novel class of anti-cancer agent that inhibits small-cell lung cancer (SCLC) cell growth in…”
    Get full text
    Journal Article
  11. 11

    [Arg , D-Trp , N Phe ]-substance P (6-11) (antagonist G) induces AP-1 transcription and sensitizes cells to chemotherapy by MACKINNON, A. C, WATERS, C, RAHMAN, I, HARANI, N, RINTOUL, R, HASLETT, C, SETHI, T

    Published in British journal of cancer (01-10-2000)
    “…[Arg(6), D-Trp(7,9), N(me)Phe(8)]-substance P (6-11) (antagonist G) inhibits small cell lung cancer (SCLC) growth and is entering Phase II clinical…”
    Get full text
    Journal Article
  12. 12

    Orbital immunoglobulin IgG4 -related inflammatory fibrosclerosing lesion treated with pentoxifylline and α-tocopherol: case report by Lee, R, MacKinnon, C.A, Aburn, N, Tan, S.T

    “…Abstract Immunoglobulin G4 (IgG4 )-related disease is a distinct group of disorders that are characterised by intense infiltration of an organ with IgG4+…”
    Get full text
    Journal Article
  13. 13

    MRI FINDINGS IN ACUTE WERNICKE'S ENCEPHALOPATHY by Zhang, L, Benjamin, P, Mackinnon, AC

    “…Background Wernicke's encephalopathy (WE) is a neurological emergency due to thiamine deficiency. The clinical triad of ophthalmoplegia, altered consciousness,…”
    Get full text
    Journal Article
  14. 14
  15. 15

    C. elegans PAT-4/ILK Functions as an Adaptor Protein within Integrin Adhesion Complexes by Mackinnon, A.Craig, Qadota, Hiroshi, Norman, Kenneth R., Moerman, Donald G., Williams, Benjamin D.

    Published in Current biology (14-05-2002)
    “…Background: Mammalian integrin-linked kinase (ILK) was identified in a yeast two-hybrid screen for proteins binding the integrin β1 subunit cytoplasmic domain…”
    Get full text
    Journal Article
  16. 16

    [3H]‐RS‐45041‐190: a selective high‐affinity radioligand for I2 imidazoline receptors by MacKinnon, Alison C., Redfern, William S., Brown, Christine M.

    Published in British journal of pharmacology (01-09-1995)
    “…1 RS‐45041‐190 (4‐chloro‐2‐(imidazolin‐2‐yl)isoindoline) is an I2 imidazoline receptor ligand with the highest affinity and selectivity so far described;…”
    Get full text
    Journal Article
  17. 17

    Blindness and severe visual impairment in facial fractures: an 11 year review by MacKinnon, Craig A., David, David J., Cooter, Rodney D.

    “…We present an 11 year review of facial fractures treated in the Australian Craniofacial Unit and the Department of Plastic and Reconstructive Surgery at the…”
    Get full text
    Journal Article
  18. 18

    HN07PSMOKING CESSATION IN PATIENTS UNDERGOING TREATMENT FOR HEAD AND NECK CANCER by Rajpal, K., Mackinnon, C. A., Tan, S. T.

    Published in ANZ journal of surgery (01-05-2009)
    “…Advice on smoking cessation is part of our overall management for head and neck cancer patients. This study determined the effectiveness of smoking cessation…”
    Get full text
    Journal Article
  19. 19

    Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain by Brown, C M, MacKinnon, A C, McGrath, J C, Spedding, M, Kilpatrick, A T

    Published in British journal of pharmacology (01-04-1990)
    “…1. The binding of [3H]-yohimbine and [3H]-idazoxan to rat cortex and hippocampus is rapid, reversible and of high affinity. Saturation data indicate that a…”
    Get full text
    Journal Article
  20. 20

    RS‐45041‐190: a selective, high‐affinity ligand for I2 imidazoline receptors by Brown, C.M., MacKinnon, A.C., Redfern, W.S., Williams, A., Linton, C., Stewart, M., Clague, R.U., Clark, R., Spedding, M.

    Published in British journal of pharmacology (01-09-1995)
    “…1 RS‐45041‐190 (4‐chloro‐2‐(imidazolin‐2‐yl)isoindoUne) showed high affinity for I2 imidazoline receptors labelled by [3H]‐idazoxan in rat (pKi = 8.66 ±0.09),…”
    Get full text
    Journal Article